Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.
Archin NM, Vaidya NK, Kuruc JD, Liberty AL, Wiegand A, Kearney MF, Cohen MS, Coffin JM, Bosch RJ, Gay CL, Eron JJ, Margolis DM, Perelson AS. Archin NM, et al. Among authors: bosch rj. Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9523-8. doi: 10.1073/pnas.1120248109. Epub 2012 May 29. Proc Natl Acad Sci U S A. 2012. PMID: 22645358 Free PMC article.
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
Albrecht MA, Bosch RJ, Hammer SM, Liou SH, Kessler H, Para MF, Eron J, Valdez H, Dehlinger M, Katzenstein DA; AIDS Clinical Trials Group 364 Study Team. Albrecht MA, et al. Among authors: bosch rj. N Engl J Med. 2001 Aug 9;345(6):398-407. doi: 10.1056/NEJM200108093450602. N Engl J Med. 2001. PMID: 11496850 Free article. Clinical Trial.
Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307.
Frank I, Bosch RJ, Fiscus S, Valentine F, Flexner C, Segal Y, Ruan P, Gulick R, Wood K, Estep S, Fox L, Nevin T, Stevens M, Eron JJ Jr; ACTG 307 Protocol Team. Frank I, et al. Among authors: bosch rj. AIDS Res Hum Retroviruses. 2004 Sep;20(9):916-26. doi: 10.1089/aid.2004.20.916. AIDS Res Hum Retroviruses. 2004. PMID: 15597521 Clinical Trial.
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.
Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman DD, Mellors JW, Coffin JM, Bosch RJ, Margolis DM. Lehrman G, et al. Among authors: bosch rj. Lancet. 2005 Aug 13-19;366(9485):549-55. doi: 10.1016/S0140-6736(05)67098-5. Lancet. 2005. PMID: 16099290 Free PMC article.
The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.
Eron JJ Jr, Bosch RJ, Bettendorf D, Petch L, Fiscus S, Frank I; Adult Clinical Trials Group 307 Protocol Team. Eron JJ Jr, et al. Among authors: bosch rj. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):249-51. doi: 10.1097/QAI.0b013e318050d61f. J Acquir Immune Defic Syndr. 2007. PMID: 17527095 Clinical Trial. No abstract available.
411 results